2227372-56-5
中文名称
(Z)-1-[2-CHLORO-2-(2,4-DICHLOROPHENYL)ETHENYL]-1H-1,2,4-TRIAZOLE HYDROCHLORIDE
英文名称
(Z)-1-[2-CHLORO-2-(2,4-DICHLOROPHENYL)ETHENYL]-1H-1,2,4-TRIAZOLE HYDROCHLORIDE
CAS
2227372-56-5
分子式
C10H7Cl4N3
分子量
310.99
MOL 文件
2227372-56-5.mol
更新日期
2025/05/07 21:35:39
2227372-56-5 结构式
基本信息
英文别名
LORECLEZOLE HYDROCHLORIDE(Z)-1-[2-CHLORO-2-(2,4-DICHLOROPHENYL)ETHENYL]-1H-1,2,4-TRIAZOLE HYDROCHLORIDE
(Z)-1-[2-CHLORO-2-(2,4-DICHLOROPHENYL)ETHENYL]-1H-1,2,4-TRIAZOLE HYDROCHLORIDE价格(试剂级)
| 报价日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
| 2025/02/08 | HY-105272A | Loreclezole hydrochloride | 2227372-56-5 | 10 mg | 5789元 |
常见问题列表
生物活性
Loreclezole hydrochloride 是一种抗癫痫化合物，是选择性的 GABAA 受体 的调节剂，是β2 或β3亚单位包含受体的正向变构调节剂。靶点
GABA A receptor.
体内研究
Loreclezole (10, 25, 50 or 75 mg/kg, i.p. 60 min before measurement of seizure threshold ) results in a dosedependent rise in seizure threshold as measured by the dose of pentylenetetrazolrequired to produce a convulsion 60 min later. Loreclezole also has the least effect on loss of muscle tone as measured by the “pull-up” test.
| Animal Model: | Adult male Lister Hooded rats. |
| Dosage: | 10, 25, 50 or 75 mg/kg. |
| Administration: | IP, 60 min before measurement of seizure threshold. |
| Result: | Resulted in a dosedependent rise in seizure threshold as measured by the dose of pentylenetetrazolrequired to produce a convulsion 60 min later. |